CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Open-market sale Chairman, CEO & President sold 143,329 shares at $114.93 ($16,472,845)
- 3/A Insider 3/A
- 4 Open-market sale Exe V-P & Pres. MMD sold 134,055 shares at an average $115.07 ($15,425,068)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President, Human Health Int?l sold 5,000 shares at $108.22 ($541,101)
- 4 Open-market sale EVP, Chief HR Officer sold 1,815 shares at $109.10 ($198,017)
- 4 Exercise or conversion EVP,Chief Info&Digital Officer acquired 1,205 shares (option exercise)
- 4 Open-market sale EVP, Chief HR Officer sold 5,000 shares at $107.00 ($535,007)
- 4 Open-market sale EVP, Chief HR Officer sold 4,436 shares at $104.25 ($462,473)
- 4 Open-market sale EVP, General Counsel sold 75,436 shares at $103.17 ($7,782,762)
- 4 Grant or award President, U.S. Market acquired 2,091 shares (grant or award)
- 4 Grant or award EVP,Chief Info&Digital Officer acquired 1,745 shares (grant or award)
- 4 Grant or award Sr. VP Fince-Global Controller acquired 2,846 shares (grant or award)
- 4 Grant or award EVP, Chief HR Officer acquired 12,192 shares (grant or award)
- 4 Grant or award EVP, General Counsel acquired 15,631 shares (grant or award)
- 4 Grant or award Executive VP & President, MRL acquired 3,275 shares (grant or award)
- 4 Grant or award CEO & President acquired 24,224 shares (grant or award)
Page 15 of 99 · 1,973 filings